Your browser doesn't support javascript.
loading
The effect of EMPAgliflozin on markers of inflammation in patients with concomitant type 2 diabetes mellitus and Coronary ARtery Disease: the EMPA-CARD randomized controlled trial.
Gohari, Sepehr; Reshadmanesh, Tara; Khodabandehloo, Hadi; Karbalaee-Hasani, Amir; Ahangar, Hassan; Arsang-Jang, Shahram; Ismail-Beigi, Faramarz; Dadashi, Mohsen; Ghanbari, Samin; Taheri, Homa; Fathi, Mojtaba; Muhammadi, Muhammad Javad; Mahmoodian, Reyhaneh; Asgari, Atieh; Tayaranian, Mohammadreza; Moharrami, Mehdi; Mahjani, Mahsa; Ghobadian, Bijan; Chiti, Hossein; Gohari, Sheida.
Afiliação
  • Gohari S; Student Research Center, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
  • Reshadmanesh T; Department of Family Medicine, Alborz University of Medical Science, Karaj, Alborz, Iran.
  • Khodabandehloo H; Student Research Center, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
  • Karbalaee-Hasani A; Department of Clinical Biochemistry, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
  • Ahangar H; Department of Clinical Biochemistry, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
  • Arsang-Jang S; Department of Cardiology, School of Medicine, Mousavi Hospital, Zanjan University of Medical Sciences, Zanjan, Iran. hassan.ahangar@yahoo.com.
  • Ismail-Beigi F; Department of Biostatistics, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
  • Dadashi M; Department of Medicine, Case Western Reserve University, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
  • Ghanbari S; Department of Cardiology, School of Medicine, Mousavi Hospital, Zanjan University of Medical Sciences, Zanjan, Iran.
  • Taheri H; Department of Cardiology, School of Medicine, Mousavi Hospital, Zanjan University of Medical Sciences, Zanjan, Iran.
  • Fathi M; Department of Cardiology, School of Medicine, Mousavi Hospital, Zanjan University of Medical Sciences, Zanjan, Iran.
  • Muhammadi MJ; Department of Clinical Biochemistry, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
  • Mahmoodian R; Student Research Center, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
  • Asgari A; Endocrinology and Metabolism Center, Department of Internal Medicine, Imam Ali Hospital, Alborz University of Medical Sciences, Karaj, Alborz, Iran.
  • Tayaranian M; Department of Cardiology, School of Medicine, Mousavi Hospital, Zanjan University of Medical Sciences, Zanjan, Iran.
  • Moharrami M; Student Research Center, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
  • Mahjani M; Student Research Center, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
  • Ghobadian B; Department of Family Medicine, Alborz University of Medical Science, Karaj, Alborz, Iran.
  • Chiti H; General Practitioner, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Gohari S; Endocrinology and Metabolism Research Centre, School of Medicine, Vali-e-Asr Hospital, Zanjan University of Medical Sciences, Zanjan, Iran.
Diabetol Metab Syndr ; 14(1): 170, 2022 Nov 17.
Article em En | MEDLINE | ID: mdl-36397128
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2022 Tipo de documento: Article